Back to results
US 2026/0201024 A1Published application
Fusion comprising anti-tau antibody and peptide and use thereof
AssigneesAdel Inc., Oscotec Inc.
InventorMi Hyang CHO
Life of this patent
Estimating the term…
Abstract
The present invention relates to a fusion and use thereof, the fusion comprising an anti-tau antibody or an antigen-binding fragment thereof and a blood-brain barrier receptor-binding peptide. The fusion of the present invention specifically binds to tau proteins by passing through the blood-brain barrier, and thus can effectively prevent or treat neurodegenerative diseases mediated by tau proteins.
Claims22
A fusion comprising (i) an anti-tau antibody or an antigen-binding fragment thereof that specifically binds to tau protein and (ii) a blood-brain barrier receptor-binding peptide.
Dependencies are inferred from the claim text.